Table 1. Patient Characteristics and... | American Society of Hematology

Table 1.

Patient Characteristics and Erythroid Colony Formation

Patient	Age/Sex	Karyotype	FAB Subtype	BFU-E^*
1	79/M	46,XY	RA	40
2	80/M	46,XY	RA	0
3	80/F	46,XX	RA	40
4	38/M	46,XY	RARS	225
5	69/M	46,XY	RAEB	0
6	33/F	46,XX t(3,12),del 7	RAEB	0
7	67/M	47,XY,+8(62%);46,XY(38%)	RAEB	0
8	63/M	46,XY	RAEB	8
9	67/F	47,XX,+8(91%);46,XX(9%)	RAEB	5
10	67/M	46,XY,del(5)(q13q35),−7,+8,−16, add19(?p or q13),−20, +R(95%);46,XY(5%)	RAEB-t	10
11	83/M	NA	RAEB-t	0
12	68/M	46,XY(3%);44-48,XY,−4,−16, −18(50%); 45-49,XY,−4,−16, −18,5q-,7q-,13q-(47%)	RAEB-t	NA
13	68/M	46,XY(90%);47-48,XY,+8(10%)	RAEB-t	18
14	27/M	46,XY	RAEB-t	9
15	42/M	46,XY	RAEB-t	0
16	64/M	46,XY(9%)46,XY,9q-(91%)	CMML	0
17	76/M	47,XY,+8	CMML	45
18	62/M	46,XY	CMML	5
19	60/M	46,XY,inv4(p15.3q11)c	CMML	15
20	46/M	46,XY	CMML	18
21	67/M	46,XY	CMML	3

Patient	Age/Sex	Karyotype	FAB Subtype	BFU-E^*
1	79/M	46,XY	RA	40
2	80/M	46,XY	RA	0
3	80/F	46,XX	RA	40
4	38/M	46,XY	RARS	225
5	69/M	46,XY	RAEB	0
6	33/F	46,XX t(3,12),del 7	RAEB	0
7	67/M	47,XY,+8(62%);46,XY(38%)	RAEB	0
8	63/M	46,XY	RAEB	8
9	67/F	47,XX,+8(91%);46,XX(9%)	RAEB	5
10	67/M	46,XY,del(5)(q13q35),−7,+8,−16, add19(?p or q13),−20, +R(95%);46,XY(5%)	RAEB-t	10
11	83/M	NA	RAEB-t	0
12	68/M	46,XY(3%);44-48,XY,−4,−16, −18(50%); 45-49,XY,−4,−16, −18,5q-,7q-,13q-(47%)	RAEB-t	NA
13	68/M	46,XY(90%);47-48,XY,+8(10%)	RAEB-t	18
14	27/M	46,XY	RAEB-t	9
15	42/M	46,XY	RAEB-t	0
16	64/M	46,XY(9%)46,XY,9q-(91%)	CMML	0
17	76/M	47,XY,+8	CMML	45
18	62/M	46,XY	CMML	5
19	60/M	46,XY,inv4(p15.3q11)c	CMML	15
20	46/M	46,XY	CMML	18
21	67/M	46,XY	CMML	3

Abbreviation: NA, not available.

Colonies per 10⁵ cells.